Long-term follow-up for TREOCAPA study children
Part of Genetic & congenital, Heart & circulation, Women’s health & pregnancy clinical trials.
This study is a long-term check-up for children who were in the TREOCAPA trial. It follows their health and development for about 2 years after they were in the original study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child took part in the TREOCAPA study before
- Your child is between 23.5 and 27.5 months old (corrected age) now
- The study team can reach you by phone or email
- Your child is not near the end of life or having a serious medical event
- You agree to continue and there are no legal reasons stopping participation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is part of a regional follow-up program for babies born very early. It looks at how these “extremely preterm” children do as they grow, and can help the care team spot needs earlier at the age-3 visit.
This study looks at how a serious heart condition before birth may affect a baby's brain development. It follows babies and their parents to better understand and support these children as they grow.
This study follows children who were born very prematurely to better understand body changes during puberty. It involves follow-up visits and special body-composition measurements to see how growth and health progress over time.
This study checks on the health and development of children whose mothers took part in the PETN studies. It involves questionnaires and a physical exam for kids aged 5 and older.
This study looks at eye structure in children who were in an earlier premature-baby eye study and are now around 4.5–5 years old. It may help researchers better understand how eye disease in prematurity develops and how to monitor it.
This study checks how children who were in the Oxy-PICU trial are doing with their development and thinking skills. Parents or caregivers answer questions to help understand long-term effects.
Hear when a new Patency of the Ductus Arteriosus Acetaminophen Extreme Prematurity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.